Document XBpQRZR8O1rBnmvXrqQ3r1yx

DRAFT August 3, 2001 AGREEMENT FOR THE CONDUCT AND FUNDING OF A RESEARCH PROGRAM ON BENZENE HEALTH RISK FROM OCCUPATIONAL EXPOSURES PURPOSE. PARTIES. AND SCOPE 1. Purpose: a. An agreement by and between the undersigned companies (hereafter the" Benzene Health Research Program/Shanghai Medical University Benzene Research Group" or "Research Group") b. The purpose of this Agreement is for the Research Group to establish and fund a research program on the Iymphohematopoietic health risks from occupational exposure to benzene (hereinafter "Program"') and to set the terms, conditions, and policies of this program, including allocation among the companies which constitute the Research Group of costs, including the costs of related expenditures and liabilities incurred by virtue of these jointly-supported data disclosure and testing activities. For the avoidance of any doubt, it is not the intent of the Research Group to set the scientific protocol of the study as this is the exclusive purview of the principal investigators with oversight by the independent scientific review panel. The Research Group is committed to the scientific integrity and independence of the principal investigators and the scientific review panel. 2. Membership - Participation in the Research Group is open to all manufacturers, distributors, suppliers and processors of benzene and benzene containing products or intermediates. Nothing in this Agreement shall preclude any member of the Testing Group from conducting its own testing, or joining any other research group. 3. Responsibility for Full Costs - Joining the Research Group commits each Company to pay its full portion of the total costs of the completed program. If a Company leaves the Research Group prior to completion of the program, it shall remain liable for payment of its full portion of the total costs of the completed program as defined in Sections 11 and 12 of this Agreement, except as provided in Section 9 of this Agreement. 4. Incorporation by Reference - With respect to conduct of the Program by API, this Agreement incorporates by reference all API Policies and SHELL-MCCLURG-051657 DRAFT Procedures. Copies of all applicable policies regarding the conduct of litigation, contracting, financial transactions and research will be provided upon request. In addition, Section 6 below will apply. 5. Data Reporting-Each participating member is responsible for any required reporting, such as T.S.C.A. 8(e). 6. Formation of Oversight Committee and Voting For the purpose of this Agreement, with the exception of paragraph 9, (paragraph 9 =Attachment A, which Shell does not have a copy of, and, therefore, cannot comment.) the Research Group shall take actions through and by means of a deliberative body of its representatives (the "Oversight Committee"). The Oversight Committee shall consist of representatives from all the companies in the Research Group. Each member of the Oversight Committee whose company is current on invoiced contributions will have one vote on all matters with the exception of funding. For funding matters, voting will be on a share basis. All resolutions and actions of the Oversight Committee shall be approved by a majority of no less than 2/3 of all votes cast, including all in absentia votes as described below in this Section. A vote may be taken only in the event of a quorum of representatives that shall have no fewer than 50% of the members of the Oversight Committee. All votes may be conducted in absentia, by mail, telephone,telefax, or e-mail return ballot, within the deadline specified for the vote. Each appointed representative may also designate a proxy. Proxies do not count for purposes of a quorum. b. Oversight Committee Responsibilities - It is agreed that the Oversight Committee has authority over such administrative and managerial obligations as, but not limited to, determining the scope of the Program pursuant to Section 9 below, the approval of contracts or other agreements with investigators, approving additional expenditure of funds, and assuring that API performs in conformance with the Program and this Agreement. The Oversight Committee shall have the authority to form subcommittees, including but not limited to an Independent Scientific Review Committee and an Independent Ethics Review Board. The Independent Scientific Review Committee shall [insert from George]. The Independent Ethics Review Board shall [insert from George]. 7. Termination - The Research Group may terminate some or all further work under this agreement upon a 2/3 vote among all members. Voting will be on a per share basis. Contractual obligations already incurred by API will be paid by participating members per the terms of this agreement. 2 SHELL-MCCLURG-051658 DRAFT 8. Scope - The scope is defined in Attachment A. Need attachment A 9. API Responsibilities API's activities under this section shall be subject to oversight and approval by the Oversight Committee and API Policies and Procedures. API agrees to submit periodic reports on the status of the Program to the Oversight Committee and the participants. a. API and the Research Group agree that API will, among other duties, negotiate, enter into, and administer agreements for the conduct and the test program. b. Provide administrative oversight for the program. c. Calculate, collect and disburse the financial contributions required of the Research Group under this Agreement. d. Communicate results to the Research Group and others as directed by the Oversight Committee e. In negotiating agreements with investigators, API agrees to use its best efforts to obtain a contractual promise and insurance coverage for negligence from the investigator(s) to fully indemnify API and participating companies. FINANCING AND ADMINISTRATION 10. Financial Contributions a. The estimated budget is a total sum of $20,000,000 for all direct and administrative costs. Direct costs include the data collection, analysis, and summary of existing data; purchase, storage and analysis of test samples; characterization of the test materials; testing to be conducted by testing laboratories; monitoring and auditing of test data, and communication of results by the Oversight Committee. Administrative costs include but are not limited to: API overhead, staff salaries, travel, 3 SHELL-MCCLURG-051659 DRAFT postage and express mail services, telephone costs, and facility costs of meetings away from the API office in Washington, D.C. b. Individual companies will pay on a share basis. The number of shares a company will have is based on the following table: Category u.s. Refiner (based in refinery capacity)* Small (:0: 500.000 bbl/day) Medium (>500.000 bbl/day and:O: 1.500.000 bbl.day) Large (> 1.500.000 bbl/day) Non-U.S. Refiner (no U.S. refineries) Free-standing Chemical Company (outside refining sector) Upstream Company (no refining operations) Other (trade association. government. NGO) Number of Shares 1 2 3 1 1 1 negotiable *U.S. refinery capacity will be determined based upon refinery ownership as of October 1. 2000. Capacity will be calculated using the Oil and Gas Journa1s 2000 Pennwell Directory. c. The maximum cost per share shall be $1.5 million. d. The oversight committee shall have authority to alter the funding formula, provided however that the maximum contribution shall not exceed the members number of shares times $1.5 million. e. Payment Schedule. [insert payment schedule] 11. Indemnification a. NOTHING IN THE AGREEMENT SHALL BE CONSTRUED TO LIMIT THE RIGHTS OF API OR ANY COMPANY TO SEEK RELIEF AGAINST ANY LABORATORY THAT IS NEGLIGENT OR VIOLATES ANY LAWS, RULES OR REGULATIONS IN CONNECTION WITH THE TESTS PERFORMED IN CONNECTION HEREWITH b. GENERAL INDEMNIFICATION - IN ADDITION TO THE PREVIOUS PROVISIONS IN THIS AGREEMENT, THE RESEARCH GROUP AGREES TO INDEMNIFY API AGAINST ALL OTHER LIABILITIES ARISING OUT OF THIS AGREEMENT EXCEPT TO THE EXTENT SUCH LIABILITIES ARE CAUSED BY THE NEGLIGENCE OR BREACH OF THIS AGREEMENT BY API. 4 SHELL-MCCLURG-051660 DRAFT MISCELLANEOUS PROVISIONS 12. Effective Date of this Agreement - The effective date of this Agreement shall be the date of execution by both parties. 13. Government Law - This Agreement shall be governed by the laws of the District of Columbia Actions brought under this Agreement shall be brought in any court of competent jurisdiction in the District of Columbia. 14. Interpretation of this Agreement - If any term of this Agreement is deemed invalid or unenforceable for any reason, the remaining terms hereof shall not be effected, impaired or invalidated and shall remain in full force and effect. 15. Modification of this Agreement - This Agreement may be amended only by a written addendum agreed to and signed by each member of the Research Group. 16. Successor Liability - The obligation imposed under this Agreement shall apply to the legal successors and assigns of the Research Group members, including any acquirer of all or substantially all of the assets of such a Company or Companies, or API. 17. Termination Date - Except as provided by paragraph 8, this Agreement and the program for which it provides shall terminate no sooner than January 1, 2007 (and no later than 2 years after completion of the last study. 18. Signature - This Agreement may be signed in multiple counterparts, which together shall constitute a single Agreement. 5 SHELL-MCCLURG-051661 DRAFT Ratification and Execution of the AGREEMENT FOR THE CONDUCT AND FUNDING OF A RESEARCH PROGRAM ON BENZENE HEALTH RISK FROM OCCUPATIONAL EXPOSURES ACCEPTED FOR: Company Name Signed Name Typed Title Date Telephone:_ _ _ _ _; Fax:_ _ _ _ _;Email:_ _ __ Contact person (If different than signer above:) Name and Title Telephone:_ _ _ _ _; Fax:_ _ _ _ _;Email:_ _ __ 6 SHELL-MCCLURG-051662 DRAFT Ratification and Execution of the AGREEMENT FOR THE CONDUCT AND FUNDING OF A RESEARCH PROGRAM ON BENZENE HEALTH RISK FROM OCCUPATIONAL EXPOSURES ACCEPTED FOR: American Petroleum Institute (not sure that it is API that we are contracting with. Aren't the companies contracting with the "Research Group?" Name Signed G. Williams Frick Vice President, General Counsel & Secretary Title Date (Name Signed) Brenda Hargett Chief Financial Officer (Title) (Date) 7 SHELL-MCCLURG-051663